Viewing Study NCT05369832


Ignite Creation Date: 2025-12-24 @ 9:37 PM
Ignite Modification Date: 2026-06-08 @ 4:42 PM
Study NCT ID: NCT05369832
Status: TERMINATED
Last Update Posted: 2025-05-20
First Post: 2022-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colitis, Ulcerative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ulcerative Colitis View
None Ozanimod View
None RPC-1063 View
None Zeposia® View
None Inflammatory bowel disease View